Metrics as of 10/17/2026, 06:56 AM (Berlin time), refresh in progress.
CHS Stock
CHS Inc.
Company data
- Sector
- Consumer Defensive
- Industry
- Agricultural Farm Products
- Country
- United States
- CEO
- Jay D. Debertin
- Employees
- 10,683
- Market cap
- $299 M
- IPO
- 15/01/2015
CHS Inc. operates as a diversified global agribusiness cooperative, providing products and services in energy, agronomy, grain marketing, animal nutrition, food ingredients, and risk management. The company supplies energy products, including refined fuels, propane, lubricants, and renewable fuels such as ethanol, and…
CHS stock: price history
1D
-2.9%
1W
-2.8%
1M
-2.8%
6M
-4.8%
YTD
-3.9%
1Y
-4.5%
2Y
-7.3%
5Y
-14.7%
10Y
-14.5%
Ask the agents about CHS
CHS stock metrics
P/E
0
P/B
0
EV/EBITDA
2.28
RETURN ON EQUITY
2.4%
NET MARGIN
2.3%
DEBT/EQUITY
0.33
DIVIDEND YIELD
7.7%
AS OF
31/05/2026
Free float & liquidity
FREE FLOAT
100.0%
FLOAT SHARES
12,267,128
AVG. DAILY VOLUME (30D)
40,788
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about CHS stock
What does CHS do?
CHS Inc. is a company in the Consumer Defensive sector, Agricultural Farm Products industry, headquartered in United States.
The CEO is Jay D. Debertin, the company employs around 10,683 people.
The IPO was on 15/01/2015; the stock trades on NASDAQ under the ticker CHSCL.
Does CHS pay a dividend?
Yes. The last dividend was US$0.47 per share, ex-date 16/09/2026, paid on 30/09/2026.
The dividend yield is 7.7% (as of 31/05/2026).
Which stocks are comparable to CHS?
Comparable stocks include Archer-Daniels-Midland Company, Bunge Global, Tyson Foods, M.P. Evans Group, AEP Plantations, Walmart, Costco Wholesale and Coca-Cola Company.
How can I get CHS stock analyzed?
Clicking "Analyze stock" lets five strategies assess CHS against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.